GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zai Lab Ltd (HKSE:09688) » Definitions » Gross Profit

Zai Lab (HKSE:09688) Gross Profit : HK$1,338 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Zai Lab Gross Profit?

Zai Lab's gross profit for the three months ended in Dec. 2023 was HK$317 Mil. Zai Lab's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,338 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Zai Lab's gross profit for the three months ended in Dec. 2023 was HK$317 Mil. Zai Lab's Revenue for the three months ended in Dec. 2023 was HK$514 Mil. Therefore, Zai Lab's Gross Margin % for the quarter that ended in Dec. 2023 was 61.66%.

Zai Lab had a gross margin of 61.66% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 9 years, the highest Gross Margin % of Zai Lab was 71.13%. The lowest was 63.80%. And the median was 65.70%.

Warning Sign:

Zai Lab Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


Zai Lab Gross Profit Historical Data

The historical data trend for Zai Lab's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zai Lab Gross Profit Chart

Zai Lab Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only 72.08 249.78 718.08 1,097.91 1,334.72

Zai Lab Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 324.47 325.41 353.28 342.49 317.02

Competitive Comparison of Zai Lab's Gross Profit

For the Biotechnology subindustry, Zai Lab's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zai Lab's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zai Lab's Gross Profit distribution charts can be found below:

* The bar in red indicates where Zai Lab's Gross Profit falls into.



Zai Lab Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Zai Lab's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=2083.022 - 748.304
=1,335

Zai Lab's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=514.119 - 197.096
=317

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$1,338 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Zai Lab's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=317 / 514.119
=61.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Zai Lab  (HKSE:09688) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Zai Lab had a gross margin of 61.66% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Zai Lab Gross Profit Related Terms

Thank you for viewing the detailed overview of Zai Lab's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Zai Lab (HKSE:09688) Business Description

Traded in Other Exchanges
Address
4560 Jinke Road, Jinchuang Plaza, Building 1, 4th Floor, Pudong, Shanghai, CHN, 201210
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Zai Lab (HKSE:09688) Headlines

No Headlines